HCPCS Level II
Q9999
Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg
Codes near Q9999
These sit next to Q9999 in the CMS Level II file. All Q codes
- Q9994In-line cartridge containing digestive enzyme(s) for enteral feeding, each
- Q9995Injection, emicizumab-kxwh, 0.5 mg
- Q9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
- Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
- Q9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 65219-0822-05 | Otulfi | FreseniUS Kabi USA, LLC | 45 |
| 65219-0824-01 | Otulfi | FreseniUS Kabi USA, LLC | 45 |
| 65219-0826-26 | Otulfi | FreseniUS Kabi USA, LLC | 90 |
| 65219-0828-05 | Otulfi | FreseniUS Kabi USA, LLC | 130 |
| 65219-0862-01 | Ustekinumab-AAUZ | FreseniUS Kabi USA, LLC | 45 |
| 65219-0866-26 | Ustekinumab-AAUZ | FreseniUS Kabi USA, LLC | 90 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.